莲湖中考补习班价格(莲湖补习机构实力成绩好) (今日更新中)

As the COVID-19 vaccine makes its way across the country and into the hands of those who need it most, many nursing homes and senior communities are anxiously waiting as they are the most vulnerable.“I’m a true Okie from Muskogee, Oklahoma,” says 80-year-old Donna. After 46 years, she and her 83-year-old husband Art made the decision to leave the countryside and move into a senior community. They chose one of the 26 Arrow Senior Living communities that are housed around the Midwest. Things were great until the pandemic hit.“Since we live on the independent side, we do our own things. Until this COVID hit, we came and went as we wanted to,”she said.Their way of living is now completely different. No visits with their three sons. No extracurricular activities. They're diligent about masks and about the proper public health measures to prevent the virus.“It's a big concern, we know this is a killer,” Donna said. “Some get a light case and some are asymptomatic and you never who’s going to get the serious case.”Which is why she's anxiously waiting for the vaccine. She remembers when the polio vaccine came out and said it was wonderful."I don’t remember people questioning it, being afraid of having it so much then as some people today but I don’t know why they’d even question it with the horrible pandemic we’ve been having,” Donna said.Stephanie Harris, CEO of Arrow Senior Living said “absolutely” when asked if she would get the vaccine. Harris says her employees will get it too. In all, nearly 4,000 people between residents and staff will need to be vaccinated.“We have been blown away at how overwhelming the response has been by our resident group, over 90% of our residents, when we surveyed them, said ‘yes’ to vaccination,” says Harris.They're not first in line, but they're not far off. They have clinics scheduled for late December, and they're excited.“I’m tired of being cooped up and taking extraordinary precautions to ensure that I could be here in this seat to support our larger operation and I want to be able to get on with some sense of normal,” Harris said.Harris added this recent surge has been brutal and it's taking an emotional toll on everyone.Holiday gatherings have been canceled, important events missed during a time when grandparents should be spending with grandkids. It's caused Arrow Senior Living to take extraordinary precautions, deploying things like mask detection technology to determine whether face coverings are being utilized. There's not one community in their network that hasn't been touched by COVID-19.“This is going to be a strange Christmas, we’re accepting it,” Donna said. “We have three sons but they’re all doing their thing. They didn’t feel like it was safe to travel and we’ll be having Christmas here.” 2789

As the east coast was hit with torrential downpours on Monday morning, the region's aging infrastructure struggled to keep up.Video posted to Twitter shows water pouring from the ceilings and down the steps into subway stations throughout New York City.According to the New York City Subway system's official Twitter account, trains began bypassing the Bryant Park station due to excess water. Video showed water raining from the ceiling and from light fixtures.  481

As parents try to safely entertain their children this summer, many have turned to trampoline parks, bounce houses and bowling alleys that have reopened. But what are the risks of this indoor fun? We asked doctors to weigh in."I think it makes me a little nervous as an infectious disease doctor. A couple reasons. One, it's bringing a lot of people in close proximity and I think we don’t really know what the potential is for transmission in children to other children and adults," said Dr. Beth Thielen, an infectious disease expert with the University of Minnesota.Dr. Thielen says there are still a lot of unknowns when it comes to how easily children can spread the coronavirus to each other. Plus, the effectiveness of masks at an indoor venue like a trampoline park could be minimal. "It's a lot of people in a potentially close space where there’s a lot of aggressive jumping and such, more respiratory secretions. Potentially similar to singing or other activities where you’re producing a lot of droplets and I think that there's real potential to spread in a confined group at this time," Dr. Thielen said.We reached out to dozens of trampoline facilities, bounce house venues and bowling alleys across the country. Only Bowlero Corporation, which also owns AMF and Bowlmor Lanes, responded, directing us to their website listing their new health and safety measures when it comes to protecting guests from COVID-19.The message on their site reads: "As we begin to reopen centers across the country, nothing is more important to us than the health and safety of our guests and staff. In addition to following State and Federal guidelines on COVID-19, we are taking precautions to ensure your visit with us will be safe."Some of their listed new safety measures include temperature checks and masks for their staff. On Launch Family Entertainment's website, which owns Launch Trampoline Park franchises nationwide, the company details their "rigorous STERILE cleanliness certification program." The national certification ensures contactless entry for guests, face masks and gloves for staff, sanitation stations plus reduced capacity.Dr. Thielen responded, "I think it all depends. The devil's in the details in terms of the number and in terms of how restricted [it is]. Is it groups of people who are all spending time together and they're quarantining together in a contained group or is it a mixed population of people from different sites that could be intermixing?" She adds, if she were forced to choose between a trampoline park, bounce house venue or bowling alley, she'd go with bowling alley."I think if people go to a bowling alley and they're wearing masks and staying in their individual space, then there's potential physical separation between people in one lane and another. That's something I would be looking at, can you maintain physical space from other people? It seems harder in a trampoline park but if that could be done safely that would be a positive factor," said Dr. Thielen. Above all, ensuring people are not sick at these indoor venues is key. And it's best to leave high risk populations, such as people with medical concerns or over the age of 60, at home. 3210

As Thousand Oaks comes to grips with the dual traumas of a deadly mass shooting and destructive wildfires, Brian Hynes will have to decide whether to reopen the Southern California bar where 12 people were killed.The Borderline Bar & Grill, the kind of place that comforted and supported the community in times of distress, is closed after a Marine veteran opened fire there last week in what authorities called a "horrific scene" before he apparently took his own life.Will the bar reopen? Hynes, the establishment's owner, said he knows how he'll come to a decision."With what Borderline is to ... my community, I don't know if (reopening) is going to feel right. But once I stand inside that building, it's going to be like going to my childhood home, and I'll know. I'll know then," he told CNN's Brooke Baldwin on Monday afternoon."There's no way I'm not going to reopen out of fear or anything like that. If it works, we will definitely reopen, but right now ... with the fires going on in our same community ... I'm trying to get people back in their home beds, with their pets and their families." 1117

As questions arise over when a coronavirus vaccine should be granted FDA approval, the leaders of several major pharmaceutical companies announced they have signed a pledge not to rush the development of a vaccine.The companies, AstraZeneca, BioNTech, GlaxoSmithKline, Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi, released a joint statement on Tuesday confirming the pledge.The pledge includes the following points:Always make the safety and well-being of vaccinated individuals our top priority.Continue to adhere to high scientific and ethical standards regarding the conduct of clinical trials and the rigor of manufacturing processes.Only submit for approval or emergency use authorization after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA.Work to ensure a sufficient supply and range of vaccine options, including those suitable for global access.There has been pressure on both the FDA and manufactures to develop and approve a vaccine for the coronavirus. There have been more than 190,000 coronavirus-related deaths in the US since March, and the economic impact of the virus has cost millions of jobs.While most developed countries have not had the same public health pain as the US, the economic impact of the virus has been felt worldwide. The International Monetary Fund estimates a nearly 5% loss in global GDP in 2020.In Russia, the country claimed to begin distributing a coronavirus vaccine despite US-based vaccine candidates likely being months away from being able to demonstrate efficacy.The pressure domestically has also ratcheted up as President Donald Trump has suggested a vaccine could be ready by this fall’s presidential election."We're going to have a vaccine very soon... maybe even before a very special date, you know what date I'm talking about,” Trump said on Monday.In late August, the CDC told states to begin to prepare distributing a vaccine by Nov. 1. But Surgeon General Jerome Adams said that just because states will be ready to help distribute a vaccine on Nov. 1 does not mean a vaccine will be ready by then."We've always said that we're hopeful for a vaccine by the end of this year or the beginning of next year,” Adams told Good Morning America."We want to make sure states are available to distribute it," he added.The companies signing on the pledge said that the FDA has strict protocols for vaccine candidates. A typical vaccine trial takes one to three years, but the companies believe only a safe and effective vaccine will be granted approval.“FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US,” the companies wrote in the pledge. “FDA’s guidance and criteria are based on the scientific and medical principles necessary to clearly demonstrate the safety and efficacy of potential COVID-19 vaccines. More specifically, the agency requires that scientific evidence for regulatory approval must come from large, high quality clinical trials that are randomized and observer-blinded, with an expectation of appropriately designed studies with significant numbers of participants across diverse populations.” 3296

来源：资阳报